Highline Wealth Partners LLC Alkermes Plc. Transaction History
Highline Wealth Partners LLC
- $297 Billion
- Q1 2025
A detailed history of Highline Wealth Partners LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Highline Wealth Partners LLC holds 143 shares of ALKS stock, worth $3,981. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143Holding current value
$3,981% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
386Shares Held
166MCall Options Held
231KPut Options Held
158K-
Black Rock Inc. New York, NY29.1MShares$810 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$515 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$341 Million0.04% of portfolio
-
State Street Corp Boston, MA8.81MShares$245 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.56MShares$210 Million3.55% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.57B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...